Back

Effects of Tofogliflozin, an Sodium-glucose co-transporter 2 Inhibitor, on Cardiac Hypertrophy in Metabolic Model Rats

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Inflammation, diabetes and their influence on the heart Drug therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Tomonari Kimura

Fukuyama Cardiovascular Hospital, Fukuyama (Japan)

6 More presentations in this session

Presentation thumbnail
The effect of apabetalone on attenuated coronary atherosclerotic plaque: insights from the ASSURE trial.
Doctor D. Shishikura (Takatsuki, JP)
Abstract Slides
Presentation thumbnail
Recombinant insulin-like growth factor-1 improves cardiac function and symptoms in the patients on the waiting list for heart transplantation with end-stage dilated cardiomyopathy
Professor K. Komamura (Toyota, JP)
Abstract Slides
Presentation thumbnail
Direct ugmentation of cholesterol efflux capacity in AMI atients: a PKPD substudy of AEGIS-I
Ms M. Yee (Boston, US)
Abstract Slides
Presentation thumbnail
Metformin epigenetically regulates tissue factor expression in diabetes
Doctor M. Witkowski (Berlin, DE)
Abstract Slides
Presentation thumbnail
Effect of TNF-a antagonists on wave reflections: a meta-analysis.
Doctor D. Terentes-Printzios (Athens, GR)

Access the full session

Session thumbnail
Inflammation, diabetes and their influence on the heart

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources